Literature DB >> 20689436

Cardiac allograft vasculopathy: do adipocytes bridge alloimmune and metabolic risk factors?

Jennifer R Wehner1, William M Baldwin.   

Abstract

PURPOSE OF REVIEW: Cardiac allograft vasculopathy (CAV) is still a major cause of chronic graft failure. CAV develops in the coronary arteries as a diffuse, concentric expansion of the intima in conjunction with inflammation and fibrosis of the adventitia. We review recent publications that could link metabolic and immunologic risk factors for CAV.A concept is offered that periarterial adipocytes may provide proinflammatory cytokines that augment immune injury of the coronary arteries. RECENT
FINDINGS: Clinical and experimental evidence indicate that some alloantibodies and autoantibodies are associated with CAV. Limited data are available on the expression of target antigens on coronary arteries at different times after transplantation. Perivascular adipose tissue is an abundant source of IL-6, IL-8 and MCP-1. Adding to the inflammatory bias, perivascular adipocytes secrete less of the anti-inflammatory adiponectin in comparison to other types of fat. Adiponectin modulates expression of adhesion molecules on the vascular endothelium. It also decreases neointimal formation in arteries following mechanical endovascular injury.
SUMMARY: Alterations in the balance between proinflammatory and anti-inflammatory cytokines secreted by perivascular fat have been implicated in atherosclerosis and restenosis. This imbalance may also augment the immune responses in the coronary arteries of transplanted hearts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20689436     DOI: 10.1097/MOT.0b013e32833deaee

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  6 in total

Review 1.  B cells in cardiac transplants: from clinical questions to experimental models.

Authors:  William M Baldwin; Marc K Halushka; Anna Valujskikh; Robert L Fairchild
Journal:  Semin Immunol       Date:  2011-09-19       Impact factor: 11.130

Review 2.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

3.  B cell clonal expansion within immune infiltrates in human cardiac allograft vasculopathy.

Authors:  Carolina Moore; Baoshan Gao; Krishna M Roskin; Elena-Rodica M Vasilescu; Linda Addonizio; Michael M Givertz; Joren C Madsen; Emmanuel Zorn
Journal:  Am J Transplant       Date:  2019-12-27       Impact factor: 8.086

Review 4.  Experimental models of cardiac transplantation: design determines relevance.

Authors:  William M Baldwin; Charles A Su; Thomas M Shroka; Robert L Fairchild
Journal:  Curr Opin Organ Transplant       Date:  2014-10       Impact factor: 2.640

5.  Evolving concepts and treatment strategies for cardiac allograft vasculopathy.

Authors:  Rodolfo Denadai Benatti; David O Taylor
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

6.  Cardiac endothelial cell-derived exosomes induce specific regulatory B cells.

Authors:  Jiangping Song; Xiao Chen; Mangyuan Wang; Yong Xing; Zhe Zheng; Shengshou Hu
Journal:  Sci Rep       Date:  2014-12-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.